North America Stem Cell Therapy Market to 2032
Overview
The North America Stem Cell Therapy Market is expected to reach a 242.31 USD Million by 2032 and is projected to grow at a CAGR of 11.88% from 2025 to 2032.
Revenue, 2024 (USD Million)
126.74
Forecast, 2032 (USD Million)
242.31
CAGR, 2024 - 2032
11.88%
Report Coverage
North America
North America Stem Cell Therapy Market 2018-2032 USD Million
North America Stem Cell Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 126.74 USD Million
- Projected Market Size (2032): 242.31 USD Million
- CAGR (2025-2032): 11.88%
Key Findings of North America Stem Cell Therapy Market
- The North America Stem Cell Therapy Market was valued at 126.74 USD Million in 2024.
- The North America Stem Cell Therapy Market is likely to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Allogeneic Stem Cell Therapy in Type Segment accounted for the largest share of the market with a revenue of 126.74 USD Million
- The fastest growing segment Gastrointestinal Diseases in Applications Segment grew Fastest with a CAGR of 17.87% during the forecast period from 2024 to 2032.
North America Stem Cell Therapy Market Scope
North America Stem Cell Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Services Companies
- Therapeutic Companies
- Hospitals and Surgical Centers
Applications
- Other Applications
- Cardiovascular Diseases
- Acute Graft-Versus-Host Disease (AGVHD)
- Gastrointestinal Diseases
- Surgeries
- Musculoskeletal Disorders
- Wounds and Injuries
Type
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Therapy
Product Type
- Others
- Adipose Tissue Derived Mesenchymal Stem Cells
- Bone Marrow Derived Mesenchymal Stem Cells
- Placental/Umbilical Stem Cell
North America Stem Cell Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 126.74 USD Million |
| Market Value in 2032 | 242.31 USD Million |
| CAGR (2025-2032) | 11.88% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Applications,Type,Product Type |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 126.74 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 126.74 USD Million in 2024.
Segments and Scope
-
North America Stem Cell Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Stem Cell Therapy Market to 2032 with a revenue of 115.56 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in North America Stem Cell Therapy Market to 2032 with a Growth rate of 12.18 % in forecast period 2025-2032.
-
North America Stem Cell Therapy Market to 2032, By End User
- Hospitals and Surgical Centers is the largest segment in North America Stem Cell Therapy Market to 2032 with a revenue of 90.21 USD Million in the year 2024.
- Hospitals and Surgical Centers is the Fastest growing segment in North America Stem Cell Therapy Market to 2032 with a Growth rate of 12.86 % in forecast period 2025-2032.
-
North America Stem Cell Therapy Market to 2032, By Applications
- Wounds and Injuries is the largest segment in North America Stem Cell Therapy Market to 2032 with a revenue of 49.75 USD Million in the year 2024.
- Gastrointestinal Diseases is the Fastest growing segment in North America Stem Cell Therapy Market to 2032 with a Growth rate of 11.44 % in forecast period 2025-2032.
-
North America Stem Cell Therapy Market to 2032, By Type
- Allogeneic Stem Cell Therapy is the largest segment in North America Stem Cell Therapy Market to 2032 with a revenue of 126.74 USD Million in the year 2024.
- Allogeneic Stem Cell Therapy is the Fastest growing segment in North America Stem Cell Therapy Market to 2032 with a Growth rate of 11.65 % in forecast period 2025-2032.
-
North America Stem Cell Therapy Market to 2032, By Product Type
- Placental/Umbilical Stem Cell is the largest segment in North America Stem Cell Therapy Market to 2032 with a revenue of 55.46 USD Million in the year 2024.
- Bone Marrow Derived Mesenchymal Stem Cells is the Fastest growing segment in North America Stem Cell Therapy Market to 2032 with a Growth rate of 9.15 % in forecast period 2025-2032.
North America Stem Cell Therapy Market Company Share Analysis
| Company Name |
|
||
| Orthofix US LLC. | |||
| Osiris Healthcare | |||
| JCR Pharmaceuticals Co., Ltd. | |||
| The Future of Biotechnology, MEDIPOST | |||
| Takeda Pharmaceutical Company Limited | |||
North America Stem Cell Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
North America Stem Cell Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Stem Cell Therapy Market is segmented based on Segmentation Distribution Channel,End User,Applications,Type,Product Type.
North America Stem Cell Therapy Market was valued at USD 126.74(Revenue in USD Million) in 2021.
North America Stem Cell Therapy Market is projected to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
The Allogeneic Stem Cell Therapy segment is expected to dominate the North America Stem Cell Therapy Market, holding a largest market share of 126.74 USD Million in 2024
North America Stem Cell Therapy Market Scope
North America Stem Cell Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Services Companies
- Therapeutic Companies
- Hospitals and Surgical Centers
Applications
- Other Applications
- Cardiovascular Diseases
- Acute Graft-Versus-Host Disease (AGVHD)
- Gastrointestinal Diseases
- Surgeries
- Musculoskeletal Disorders
- Wounds and Injuries
Type
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Therapy
Product Type
- Others
- Adipose Tissue Derived Mesenchymal Stem Cells
- Bone Marrow Derived Mesenchymal Stem Cells
- Placental/Umbilical Stem Cell
Frequently Asked Questions
The North America Stem Cell Therapy Market is segmented based on Segmentation Distribution Channel,End User,Applications,Type,Product Type.
North America Stem Cell Therapy Market was valued at USD 126.74(Revenue in USD Million) in 2021.
North America Stem Cell Therapy Market is projected to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
The estimated market value of the North America Stem Cell Therapy Market for final year is USD 242.31 (USD Million).
North America Stem Cell Therapy Market Company Profiling
Frequently Asked Questions
The North America Stem Cell Therapy Market is segmented based on Segmentation Distribution Channel,End User,Applications,Type,Product Type.
North America Stem Cell Therapy Market was valued at USD 126.74(Revenue in USD Million) in 2021.
North America Stem Cell Therapy Market is projected to grow at a CAGR of 11.88% during the forecast period of 2024 to 2032.
The estimated market value of the North America Stem Cell Therapy Market for final year is USD 242.31 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.